ConductScience.org, home

Trial · NCT04644367

Effects of a Biomechanical-based Tai Chi Program on Gait and Posture in People With Parkinson's Disease

NCT04644367, Not applicable, Completed, University of Ottawa

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Effects of a Biomechanical-based Tai Chi Program on Gait and Posture in People With Parkinson's Disease. Trials, record NCT04644367. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04644367

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of a Biomechanical-based Tai Chi Program on Gait and Posture in People With Parkinson's Disease
NCT number
NCT04644367
Status
Completed
Phases
Not applicable
Enrollment
40 participants, actual
Lead sponsor
University of Ottawa
Conditions
Parkinson Disease
Interventions
Tai Chi intervention, Regular Physical Activity (control) group
First posted
2020-11-25
Last updated
2022-10-04

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Center of Mass-Center of Pressure (COM-COP) Separation Distancebaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
The COM-COP separation distance will be determined from the 3D-motion capture data. The participants will be asked to walk at a self-selected/comfortable pace and to crossover a 20-centimeter-high obstacle placed in the middle of the walkway (5 trials; averaged reported in meters).
PrimaryChange in Clearance Distance Heightbaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
The clearance distance of the toe and heel will be determined from the 3D-motion capture data. The participants will be asked to walk at a self-selected/comfortable pace and to crossover a 20-centimeter-high obstacle placed in the middle of the walkway (5 trials; averaged reported in centimeters). This distance will be determined by the marker position of the heel/toe away from the top of the obstacle.
SecondaryMontreal Cognitive Assessment (MoCA)baseline
The participants will be administered a set of instructions and be asked to perform a series of cognitive and motor tasks. The total time to administer the MoCA is approximately 10 minutes. The total possible score is 30 points.
SecondaryChange in Balance, Lower-limb Muscle Strengthbaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
Balance and lower-limb muscle strength will be assessed using the Single-leg Stance Test with Eyes Open (SLO) and Closed (SLC). The participant will be asked to stand for as long as possible up to 60 seconds, with either eyes open or closed. Trials will be terminated if the participant loses his or her balance, or if his or her feet are moved from the initial position (randomized order; 3 trials; averaged time of trials reported in second).
SecondaryChange in Mobilitybaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
Mobility will be assessed using the Timed Up and Go (TUG) test. The participants will be instructed to stand up from a chair, walk 3 meters as quick and safely as possible, cross a line marked on floor, turn around, walk back, and sit down (3 trials; time of each trial recorded in seconds).
SecondaryChange in Mental Flexibilitybaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
Mental flexibility will be assessed using the Wisconsin Card Sorting Test (WCST). The participants will be given a deck of 64-cards and will be asked to sort the cards by shape, color, or number. The number of errors made, and number of successful sorted categories (maximum of 6) will be recorded (3 trials; number of errors made recorded).
SecondaryChange in Processing Speedbaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
Processing speed will be assessed using the Trail Making Test Part B (TMT-B). The participants will be given a set of numbers and letters that they will be asked to connect with lines the numbers to letters in ascending order. The time that it takes the participant to complete this task will be recorded (3 trials; completion time of each trial recorded in seconds).
SecondaryChange in Mental Switchingbaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
Mental switching will be assessed with the Stroop Test. The participants will be asked to name the color but not to read the word on a card. A color-word score will be given based on the total correct identification of the correct color within 45 seconds (3 trials; the total score scored out of 40).
SecondaryChange in Walking Speedbaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
Walking speed will be determined from the 3D-motion capture data collected along an 8-meter-long walkway. The participants will be asked to walk along the walkway at self-selected/comfortable pace (5 trials; averaged reported in m/s).
SecondaryChange in Walking Cadencebaseline, 6 weeks (mid-intervention), and 12 weeks (post-intervention)
Walking cadence will be determined from the 3D-motion capture data collected along an 8-meter-long walkway. The participants will be asked to walk along the walkway at self-selected/comfortable pace (5 trials; averaged reported in steps or cycles/min).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
36602886DERIVEDPubMed
37386473DERIVEDPubMed
38588457DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Card Sorting Test (Berg)Secondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Trail Making Test BSecondary outcomeConductCognition

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04644367

GET https://conductscience.org/api/trials/v1/NCT04644367/registered